GEPSMAN MARTIN J 4
4 · CME GROUP INC. · Filed Jun 29, 2026
Research Summary
AI-generated summary of this filing
CME Group Director Martin J. Gepsman Receives 645-Share Award
What Happened Martin J. Gepsman, a director of CME Group Inc. (CME), was granted 645 shares of Class A common stock as an award on 2026-06-25. The reported grant value is based on a $225.00 per-share price, totaling $145,125. This transaction is an award (code A) under the company's director equity program — not an open-market purchase or sale.
Key Details
- Transaction date: 2026-06-25; Price reported: $225.00 per share; Total value: $145,125.
- Transaction type: Award/Grant (code A).
- Shares owned after the transaction: Not specified in the provided filing.
- Footnote: Shares are fully vested and issued under the CME Group Director Stock Plan for non-employee directors; they are not subject to any vesting conditions.
- Filing timeliness: Report filed 2026-06-29 (timely — within two business days of the transaction).
Context This grant is part of routine director compensation and represents stock awards rather than an insider purchase or sale. Such awards compensate service and do not, by themselves, indicate the director’s trading sentiment.
Insider Transaction Report
Form 4
GEPSMAN MARTIN J
Director
Transactions
- Award
Common Stock Class A
[F1]2026-06-25$225.00/sh+645$145,125→ 25,644 total
Footnotes (1)
- [F1]Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.
Signature
/s/ Elizabeth Hensen, as Attorney-in-Fact for Martin J. Gepsman|2026-06-29